期刊文献+

补体片段C3f、DRC3f对皮肤成纤维细胞合成和分泌转化生长因子-β1的调节作用 被引量:4

The Modulation of Complement C3f and DRC3f on Production of Transforming Growth Factor(TGF)-β1 by Normal Human Adult Dermal Fibroblasts
下载PDF
导出
摘要 目的观察补体C3水解片段C3f和去精氨酸C3f(C3f-des-arginine,DRC3f)对皮肤成纤维细胞合成与分泌转化生长因子-β1(transforming growth factor-β1,TGF-β1)的影响。方法采用人工合成的C3f(17肽)和DRC3f(16肽)刺激培养的正常成人皮肤成纤维细胞(NHDF-Ad),通过半定量逆转录多聚酶链式反应方法(RT-PCR)和酶联免疫法(ELISA)从mRNA和蛋白水平检测TGF-β1生成量。结果培养的正常成纤维细胞生成极微量TGF-β1(8 pg/ml)。C3f和DRC3f能够提高皮肤成纤维细胞TGF-β1生成量(P<0.05),且呈剂量依赖性。结论补体C3水解片段C3f和DRC3f提高皮肤成纤维细胞TGF-β1生成量的作用,可能对皮肤胶原纤维过度沉积起着促进作用。 Objective The increase of Complement C3f -dse -arginine (DRC3f) was found in systemic sclerosis (SSc) in our study recently. This report is aimed to investigate the influence of synthesized C3f and DRC3f on production of TGF - β1 by normal human adult dermal fibroblasts (NHDF- Ad). Methods The cultured NHDF- Ad was stimulated with synthesized C3f and DRC3f,the TGF -61 mRNA in the cells was detected by semi- quantitative reverse -transcriptional PCR ( RT - PCR), while the TGF - β1 molecules in the supernatant of the cells were measured by enzyme linked immunosorbent assay (ELISA). Results The cultured NHDF - Ad only produced trace of TGF -β1 (7 ng/ml). After stimulation by C3f or DRC3f, the expression of TGF - β1 at both mRNA and protein levels in NHDF - Ad was increased significantly in dose - dependent manner. Conclusions These results suggest that the up - regulation of TGF - βin NHDF-Ad by C3f and DRC3f may participate in the type Ⅰ collagen over- expression and deposit in skin of patients with SSc.
出处 《湖北民族学院学报(医学版)》 2007年第1期10-13,共4页 Journal of Hubei Minzu University(Medical Edition)
关键词 补体片段C3f 去精氨酸C3f 转化生长因子Β1 皮肤成纤维细胞 Complement component C3f C3f desarginine TGF -β1 Dermal fibroblasts
  • 相关文献

参考文献8

  • 1Rodnan GP,Myerowitz RL,Justh GO.Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud phenomenon[J].Medicine (Baltimore),1980,59(6):393-408.
  • 2Harrison RA,Farries TC,Northrop FD,Lachmann PJ,Davis AE.Structure of C3f,a small peptide specifically released during inactivation of the third component of complement[J].Complement,1988,5(1):27-32.
  • 3Ganu VS,Muller-Eberhard HJ,Hugli TE.Factor C3f is a spasmogenic fragment released from C3b by factors I and H:the heptadeca-peptide C3f was synthesized and characterized[J].Mol Immunol,1989,26(10):939-948.
  • 4Benbassat C,Schlesinger M,Luderschmidt C,Valentini G,Tirri G,Shoenfeld Y.The complement system and systemic sclerosis[J].Immunol Res,1993,12(3):312-316.
  • 5Senaldi G,Lupoli S,Vergani D,Black CM.Activation of the complement system in systemic sclerosis.Relationship to clinical severity[J].Arthritis Rheum,1989,32(10):1262-1267.
  • 6Dousset B,Straczek J,Maachi F,Nguyen DL,Jacob C,Capiaumont J,et al.Purification from human plasma of a hexapeptide that potentiates the sulfation and mitogenic activities of insulin-like growth factors[J].Biochem Biophys Res Commun,1998,247(3):587-591.
  • 7Xiang Y,Matsui T,Matsuo K,Shimada K,Tohma S,Nakamura H,et al.Comprehensive Investigation of Disease-Specific Short Peptides in Sera from Patients with Systemic Sclerosis (SSc):Complement C3f-des-arginine (DRC3f),Detected Dominantly in SSc,Enhances Proliferation of Vascular Endothelial Cells[J].Arthritis Rheum,2007,in press.
  • 8Postlethwaite AE.Connective tissue metabolism including cytokines in scleroderma[J].Curr Opin Rheumatol,1995,7(6):535-540.

同被引文献61

  • 1胡永斌,曾庆富,彭劲武,初令,李翔,王金胜,蒋海鹰,文继舫.二氧化硅影响人肺成纤维细胞α-平滑肌肌动蛋白表达的实验研究[J].中华劳动卫生职业病杂志,2006,24(9):523-525. 被引量:8
  • 2HU Y,ZHANG S,YU J,et al.SELDI-TOF-MS:the proteomics and bioinformatics approaches in the diagnosis of breast cancer[J].The Breast,2005,14(4):250-255.
  • 3KIM K J,CHO S B.Prediction of colon cancer using an evolutionary neural network[J].Neurocomputing,2004,61:361-379.
  • 4HUANG C J,LIAO W C.Application of probabilistic neural networks to the class prediction of leukemia and embryonal tumor of central nervous system[J].Neural Processing Letters,2004,19(3):211-226.
  • 5BONISSONE P P,HENRION M,KANAL L N,et al.Uncertainty in artificial intelligence 6[M].Elsevier Science Pub Co,1991.
  • 6ROTHER K,TILL G O,HNSCH G M.The complement system[M].Springer Verlag,1998.
  • 7HORTIN G L.The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome[J].Clinical Chemistry,2006,52(7):1 223-1 237.
  • 8CHANG J,CHEN L C,WEI S Y,et al.Increase diagnostic efficacy by combined use of fingerprint markers in mass spectrometry-plasma peptidomes from nasopharyngeal cancer patients for example[J].Clinical biochemistry,2006,39(12):1 144-1 151.
  • 9LEE I N,CHEN C H,SHEU J C,et al.Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach[J].Proteomics,2006,6(9):2 865-2 873.
  • 10LI J,ORLANDI R,WHITE C N,et al.Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry[J].Clinical Chemistry,2005,51(12):2 229-2 235.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部